Xact Kapitalforvaltning AB strengthens its stake in Endo International PLC (ENDP)



[ad_1]

  Endo International logo Xact Kapitalforvaltning AB lifted its equity stake in Endo International PLC (ENDA) (TSE: ENL) by 44.5% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission.The institutional investor held 29,215 shares of the company after the acquisition of 9,000 additional shares during the quarter.Xact Kapitalforvaltning AB's interests in Endo International were worth 174 $ 000 to

Several other institutional investors and hedge funds recently added or reduced their holdings in ENDP Paloma Partners Management Co bought a new equity stake in Endo International during the fourth quarter, with a total of worth $ 122,000. Partners LLC purchased a new equity interest in Endo International during the fourth quarter valued at $ 194,000. Neuburgh Advisers LLC increased its stake in Endo International shares by 84.2% in the first quarter. Neuburgh Advisers LLC now holds 36,234 shares of the company valued at $ 215,000 following the acquisition of 16,566 additional shares during the last quarter. Riverhead Capital Management LLC increased its stake in Endo International shares by 83.9% in the first quarter. Riverhead Capital Management LLC now holds 41,218 shares of the company valued at $ 245,000 after acquiring 18,800 additional shares in the last quarter. Lastly, Tyers Asset Management LLC increased its stake in Endo International shares by 84.2% during the first quarter. Tyers Asset Management LLC now holds 46,116 shares of the company valued at $ 274,000 after acquiring 21,084 additional shares in the last quarter. 98.40% of the shares are held by institutional investors and hedge funds.

ENDP opened at $ 11.15 Friday. The company has a ratio of 0.88, a ratio of 1.06 and a debt ratio of -1,161.84. Endo International PLC has a low of $ 12.27 in 12 months and a high of $ 12.46 in 12 months. The company has a market capitalization of $ 2.51 billion, a venture capital ratio of 3.42, a P / E ratio of 4.69 and a beta of 0.34.

Endo International (NASDAQ: ENDP) (TSE: ENL) has announced its quarterly results for the last time on Tuesday, May 8th. The company reported earnings per share (EPS) of $ 0.67 for the quarter, exceeding Thomson Reuters consensus estimate by $ 0.12 by $ 0.55. Endo International recorded a return on equity of 143.46% and a negative net margin of 75.58%. The company achieved a turnover of $ 700.53 million during the quarter, compared with $ 691.94 million for badysts. During the same period last year, the company earned 1.23 dollar earnings per share. The quarterly business figure of Endo International is down 32.5% over the same quarter of last year. sell-side badysts predict that Endo International PLC will post earnings per share of 2.39 for the current year.

A number of research firms have recently published reports on the ENDP. BidaskClub has updated Endo International from a "buy" rating to a "strong buy" rating in a report released on Saturday. Deutsche Bank has set a target price of $ 11.00 on Endo International and awarded the company a "buy" rating in a report released on Wednesday. Zacks Investment Research lowered Endo International from a "hold" rating to a "sell" rating in a report on Monday, July 16th. Citigroup reprocessed a buy-in note on Endo International shares in a report on Wednesday, July 11th. Finally, B. Riley increased his target price on Endo International from $ 10.00 to $ 13.00 and gave the company a "buy" rating in a report on Thursday, June 28th. Three badysts rated the stock with a sales note, thirteen issued a reserve note, four gave a purchase rating and two gave a strong rating to the company. The company has an average rating of "Hold" and an average price of $ 9.36

About Endo International

Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceutical products in the United States, Canada and internationally. The company operates through three segments: US Generic Pharmaceuticals, US Branded Pharmaceuticals, and International Pharmaceuticals.

Further reading: What does the relative strength index mean?

  Institutional Ownership by Quarter for Endo International (NASDAQ: ENDP)



Receive news and ratings of Endo International Daily – Enter your email address below to receive a concise summary of the latest news and notes from badysts for Endo International and related companies with MarketBeat.com's free daily newsletter.

[ad_2]
Source link